Phenprocoumon

CAS: 435-97-2

Ref. 3D-AAA43597

Produktinformation

• Name: Phenprocoumon
• Synonyme: (.+-.)-Phenprocoumon, 3-(1-Phenylpropyl)-4-hydroxycoumarin, 3-(α-Ethylbenzyl)-4-hydroxycoumarin, 3-(α-Phenylpropyl)-4-hydroxycoumarin, 4-Hydroxy-2-oxo-3-(1-phenylpropyl)-2H-chromene, 4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one, <span class="text-smallcaps">DL</span>-3-(α-Ethylbenzyl)-4-hydroxycoumarin, Bs 7565, Coumarin, 3-(α-ethylbenzyl)-4-hydroxy-, DL-3-(α-Ethylbenzyl)-4-hydroxycoumarin, Falithrom, Fencumar, Fenprocoumona, Liquamar, Marcoumar, Marcumar, Phenprocoumarol, Phenprocoumarole, Phenprocoumone, Phenprocumon, Ro 1-4849
• CAS: 435-97-2

Beschreibung

Phenprocoumon is a drug that belongs to the class of coumarin derivatives. It is used as an oral anticoagulant for the prevention and treatment of thrombosis or embolism in patients with atrial fibrillation, chronic deep venous thrombosis, or pulmonary embolism. Phenprocoumon prevents clot formation by inhibiting vitamin K-dependent factors necessary for blood coagulation. This drug may also be used to control bleeding in persons with hemophilia A or B. Phenprocoumon has been shown to decrease the rate of myocardial infarction (heart attack) and mortality rates in patients who have had a previous myocardial infarction. The mechanism by which phenprocoumon works is not well understood but it is known that this drug may interact with other drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs).

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 280.32 g/mol
• Formel: C₁₈H₁₆O₃
• Reinheit: Min. 95%